Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How We Collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study

Submitted by Frida Mäkelä on Thu, 01/30/2025 - 15:56
  • Read more about Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study

Complex interplay of neurodevelopmental disorders (NDDs), fractures, and osteoporosis: a mendelian randomization study

Submitted by Frida Mäkelä on Thu, 01/30/2025 - 15:52
  • Read more about Complex interplay of neurodevelopmental disorders (NDDs), fractures, and osteoporosis: a mendelian randomization study

Causal relationship between nutritional assessment phenotypes and heart failure: A Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 01/30/2025 - 15:48
  • Read more about Causal relationship between nutritional assessment phenotypes and heart failure: A Mendelian randomization study

Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma

Submitted by Frida Mäkelä on Thu, 01/30/2025 - 15:42
  • Read more about Systematic proteome-wide Mendelian randomization using the human plasma proteome to identify therapeutic targets for lung adenocarcinoma

Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational study

Submitted by Frida Mäkelä on Thu, 01/30/2025 - 15:36
  • Read more about Statins as a risk factor for diabetic retinopathy: a Mendelian randomization and cross-sectional observational study

Lifestyle factors, glycemic traits, and lipoprotein traits and risk of liver cancer: a Mendelian randomization analysis

Submitted by Frida Mäkelä on Thu, 01/30/2025 - 14:54
  • Read more about Lifestyle factors, glycemic traits, and lipoprotein traits and risk of liver cancer: a Mendelian randomization analysis

Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis

Submitted by Frida Mäkelä on Thu, 01/30/2025 - 14:52
  • Read more about Integrative multi-omics analysis identifies genetically supported druggable targets and immune cell specificity for myasthenia gravis

Decoding triancestral origins, archaic introgression, and natural selection in the Japanese population by whole-genome sequencing

Submitted by Frida Mäkelä on Thu, 01/30/2025 - 14:45
  • Read more about Decoding triancestral origins, archaic introgression, and natural selection in the Japanese population by whole-genome sequencing

Dissecting the shared genetic landscape of anxiety, depression, and schizophrenia

Submitted by Frida Mäkelä on Thu, 01/30/2025 - 14:39
  • Read more about Dissecting the shared genetic landscape of anxiety, depression, and schizophrenia

Identifying the causal relationship between immune factors and osteonecrosis: a two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 01/30/2025 - 14:34
  • Read more about Identifying the causal relationship between immune factors and osteonecrosis: a two-sample Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 154
  • Page 155
  • Page 156
  • Page 157
  • Current page 158
  • Page 159
  • Page 160
  • Page 161
  • Page 162
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement